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http:WHAT THIS PAPER ADDS
This review provides the ﬁrst systematic evaluation of behaviour-change techniques in addition to exercise
therapy on walking capacity and behaviour in patients with intermittent claudication. It identiﬁes 11 behaviour-
change techniques that have been applied to individuals with intermittent claudication in order to increase
walking. Barrier identiﬁcation with problem solving, self-monitoring and feedback on performance are
behaviour-change techniques that could be easily applied in clinical practice when prescribing exercise or giving
advice to walk. There is a need for high-quality trials examining the effectiveness of behaviour-change tech-
niques in addition to exercise therapy for improving patient outcomes.This systematic narrative review of randomised controlled trials (RCTs) identiﬁes and evaluates the efﬁcacy of
behaviour-change techniques explicitly aimed at walking in individuals with intermittent claudication. An
electronic database search was conducted up to December 2012. RCTs were included comparing interventions
incorporating behaviour-change techniques with usual care, walking advice or exercise therapy for increasing
walking in people with intermittent claudication. Studies were evaluated using the Cochrane Collaboration risk of
bias tool. The primary outcome variable was maximal walking ability at least 3 months after the start of an
intervention. Secondary outcome variables included pain-free walking ability, self-report walking ability and daily
walking activity. A total of 3,575 records were retrieved. Of these, six RCTs met the inclusion criteria. As a result
of substantial heterogeneity between studies, no meta-analysis was conducted. Overall, 11 behaviour-change
techniques were identiﬁed; barrier identiﬁcation with problem solving, self-monitoring and feedback on
performance were most frequently reported. There was limited high-quality evidence and ﬁndings were
inconclusive regarding the utility of behaviour-change techniques for improving walking in people with
intermittent claudication. Rigorous, fully powered trials are required that control for exercise dosage and
supervision in order to isolate the effect of behaviour-change techniques alongside exercise therapy.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Intermittent claudication (IC) caused by lower-extremity
peripheral arterial disease (PAD) is a debilitating condi-
tion, affecting walking ability, health status and quality of
life.1e3 In addition to adequate treatment of the underlying
arteriosclerotic disease, improving walking ability is an
important clinical aim.
Exercise, and particularly walking, is a key component of
disease management,4,5 with gains of up to 200% inresponding author. M.N.Galea King’s College London, Division of
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//dx.doi.org/10.1016/j.ejvs.2013.03.030maximal walking ability achieved following supervised ex-
ercise therapy (SET).6 SET is frequently treadmill-based and
conducted in facilities where patients are supervised by
healthcare professionals. Guidelines recommend SET on at
least 3 days per week for at least 30 minutes.4 Over the long
term, SET might be more effective than standard pharma-
ceutical therapy,7,8 and endovascular treatment or surgical
treatment6,7 in improving walking ability.
However, the long-term effectiveness of SET relies on
adherence to exercise, which is variable,6 and the impact on
long-term unsupervised walking behaviour in the commu-
nity is unclear.6 Moreover, recent international data suggest
that less than one-third of vascular surgeons have access to
SET to which patients can be referred.9 As a result of these
resource limitations, individuals often receive only instruc-
tion to walk in their community, although fewer than one-
half of IC patients follow such advice.10 People with IC
M.N. Galea et al. 133report lack of speciﬁc instructions, uncertainty regarding the
outcome of walking exercise, the presence of comorbidities
and pain tolerance among barriers to engaging in regular
walking.10,11
Adherence to a home-based exercise prescription re-
quires the individual to change their behaviour, either by
adopting a new regimen or altering their current exercise.
Increasing walking behaviour in people with IC presents a
particular challenge, as walking gives rise to pain and may
seem neither logical nor necessary to the individual.
Although walking advice or SET may support behaviour
change, for example, by providing information on how to
perform walking exercise or through the provision of social
support, data on activity levels among individuals with
IC10,12 suggest that more deliberate strategies are necessary
for lifestyle changes to occur. Therefore, skills for regulating
thoughts and actions must be learned.13
Speciﬁc behaviour-change techniques (BCTs) based on
existing psychosocial models of health-related behaviours
have been identiﬁed, which could be implemented in
clinical practice in order to increase unsupervised exercise,
such as walking.14 These target individual motivation, and
range from simple tasks, such as keeping a diary to monitor
activity or setting behavioural goals, to complex psycho-
logical techniques including motivational interviewing (dis-
cussing and exploring ways to minimise resistance and
ambivalence toward behaviour change with the individ-
ual)15 and action planning (detailed preparation of when,
where and how the individual will engage in a behaviour).16
Therefore, if it is possible to identify techniques, or com-
binations of techniques, that have been successfully
applied to increase walking in people with IC, then these
could be applied in addition to walking prescriptions (that
is, walking advice or SET) in order to achieve greater
outcomes.
To date, evidence from interventions employing BCTs
among individuals with IC has not been systematically
evaluated. We conducted a systematic review of rando-
mised controlled trials (RCTs) to evaluate whether BCTs
improve measures of functional walking or walking behav-
iour among individuals with IC, and to identify if any
particular techniques were successful.
METHODS
Eligibility criteria
Studies were eligible for inclusion if they were RCTs of in-
dividuals diagnosed with PAD and IC.4 Intervention groups
must have received treatment incorporating at least one
BCT, as deﬁned by Michie et al.,14 that explicitly targeted
walking behaviour.Walking advice was considered as part of
usual care and was not included as a behaviour-change
technique. Eligible control groups included patients
receiving walking advice alone, usual care or attention
placebo, but no administration of BCTs. Studies were
excluded if both intervention and control groups received
BCTs or if outcome variables were not reported at least 3
months following the start of an intervention.Primary outcome
The primary outcome variable was maximal walking ability
(MWA) assessed by treadmill or corridor walk test. MWA is
a reliable quantitative marker of ambulatory performance in
people with IC,17 and represents the distance or duration an
individual can walk before they need to stop and rest.Secondary outcomes
Secondary outcome variables included: pain-free walking
ability (PFWA) assessed by treadmill or corridor walk test,
which represents the distance or duration an individual can
walk before they report the onset of pain; self-report
walking ability, assessed by distance and speed scores on
the Walking Impairment Questionnaire (WIQ),18 and daily
walking activity, assessed by self-report or using an activity
monitor. All outcome variables were evaluated at least 3
months following the start of an intervention, with the
longest follow-up assessment reported.Data sources and search strategies
An electronic database search (Supplementary Fig. 1) was
conducted using Medline, PsychINFO, Embase, CINAHL and
Web of Science and by cross-checking reference lists of
retrieved full-text articles. The OpenSINGLE database was
searched for any appropriate grey literature and the active
register of the metaRegister of Controlled Trials was
searched for in-progress and unpublished trials. No lan-
guage restrictions were imposed and databases were
searched from their earliest records to December 2012.
Search results were downloaded into bibliographic software
(EndNote X6; Thompson Reuters, New York, NY, USA).
Search terms included MeSH, keyword and wild-card
terms located in the title or abstract for three broad con-
cepts reﬂecting the disease (e.g., intermittent claudication,
peripheral arterial disease), psychological interventions or
variables (e.g., behaviour modiﬁcation, motivation, inter-
vention) and outcome (e.g., walking, exercise).Study selection
Titles and abstracts of records were screened for eligibility
by two investigators (MG and LB), and the full texts of
retained articles were reviewed by two investigators (MG
and LB) independently using a bespoke screening tool that
was designed and piloted a priori. Disagreement between
reviewers was resolved following discussion.Data collection and computation
A data extraction tool was developed based on a template
from the Cochrane Peripheral Vascular Diseases Review
Group. This was pilot-tested on a selection of studies and
reﬁned as necessary. Data were collected on methods,
study design, participants, intervention components and
key outcome variables. At least two of four reviewers (MG,
CW, LB and SJB) extracted data from all included studies.
Disagreement was resolved by discussion.
134 European Journal of Vascular and Endovascular Surgery Volume 46 Issue 1 July/2013Mean differences (MD) and 95% CIs were calculated for
data on MWA, PFWA and daily walking activity, where
possible, using Review Manager 5 (Cochrane IMS); if sufﬁ-
cient data to calculate MD were unavailable, percentage
change scores were calculated: ([baseline score  follow-up
score]/baseline score)  100. Scores for self-report walking
ability were converted from ratio or percentage values to
reﬂect a range from 0 to 100 on the WIQ.Risk of bias in individual studies and level of evidence
Study quality was evaluated using the Cochrane Collabo-
ration tool for assessing risk of bias.19 Individual RCTs were
rated as having high risk of bias (i.e., “low-quality” trials) or
low to moderate risk of bias (i.e., “high-quality” trials) if
there was evidence for the presence of 3 or <3 sources
of bias respectively. In addition, RCTs were appraised using
a 27-item checklist developed by Downs and Black,20,21
which provided a broader evaluation of study quality,
including reporting, internal and external validity, and3, 575 records identified 
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Figure 1. Flow diagram illustrating the process of study selection for a
individuals with intermittent claudication (IC). Note. BCT ¼ behaviour-
were identiﬁed from the OpenSINGLE database or metaRegister of Copower. The maximum possible score for study quality using
this scale is 31. The cumulative level of evidence from
multiple studies, deﬁned as “strong”, “moderate”, “limited”,
“conﬂicting” or “none”, was determined for each outcome
variable in accordance with recommendations by van
Tulder et al.22RESULTS
Study selection
Six studies were identiﬁed for inclusion in the review.8,23e27
The initial database search resulted in 3,575 identiﬁed re-
cords. After duplicates were removed, 2,328 records
remained, of which 2,200 studies were excluded based on
the content of their titles and abstracts. Full texts of the
remaining 128 articles were reviewed, of which a further
122 articles were excluded (Fig. 1).
Because of the heterogeneity of behaviour-change in-
terventions, exercise prescriptions and outcome measurestional records 
ified through
er sources
 2,200 records excluded 
122 full-text articles 
excluded
No BCT 72
Outcome criteria 
unmet 10
Unobtainable 8b
Non-RCT 23
Not translated 4
Same cohort 3
Non-IC patients 1
Active control group 1
systematic review on behaviour-change techniques and walking in
change technique; RCT ¼ randomised controlled trial. aNo records
ntrolled Trials. bUnavailable through a national library catalogue.
M.N. Galea et al. 135used, a narrative synthesis of the six included studies was
conducted without meta-analysis.
Characteristics of included studies
Study design and participants. Six RCTs evaluating BCTs to
increase walking in IC, with a total of 434 participants, were
included (Table 1). Two RCTs were pilot studies26,27 and one
was a PhD thesis.25 The number of participants ranged from
2327 to 145.23 Mean age was 67.3 years and 64% (n ¼ 277/
434) were male, reﬂecting the age and gender distribution
of PAD in the general population.4 Baseline clinical mea-
sures were similar between control and intervention groups
in all included studies, with the exceptions that one study
reported a signiﬁcantly higher MWA25 and one reported
greater medication use for IC23 among the control group
participants.
Intervention composition and setting. BCTs were adminis-
tered in conjunction with walking advice in four studies8,25e
27 and with walking advice plus SET in two studies.23,24 In-
terventions ranged in the number of BCTs applied from
one24,27 up to seven.23 Two interventions were delivered
through group sessions24,25 and four during individual
consultation.8,23,26,27 Among the interventions delivered on
an individual basis, two were delivered at a research centre
or hospital,8,27 one included a baseline consultation plus
telephone follow-up23 and one was delivered in partici-
pants’ homes.26
Identiﬁed behaviour-change techniques. Overall, 11 BCTs14
were identiﬁed in the included studies (Table 2). The most
frequent techniques reported were prompting self-
monitoring of behaviour (n ¼ 3),8,23,25 feedback on per-
formance (n ¼ 3)8,23,25 and barrier identiﬁcation and
problem solving (n ¼ 3).23,25,26 Other BCTs included moti-
vational interviewing (n ¼ 2),26,27 providing follow-up
prompts (n ¼ 2),23,25 information on the consequences of
the behaviour in general (n ¼ 2),24,26 behavioural goal
setting (n ¼ 2)23,26 and planning social support (n ¼ 2).23,25
Action planning,26 use of a behavioural contract25 and
prompting practice of the behaviour23 were each reported
once.
Control groups. Control groups received walking advice in
four studies,8,24,25,27 and walking advice or usual care plus
attention placebo in two studies.23,26 One study8 was a
three-arm trial comparing home-based exercise therapy
with SET or walking advice; for the purposes of this review,
we report results of comparisons between home-based
exercise therapy and walking advice only, as the home-
based exercise therapy group were engaged in self-
monitoring and received feedback on performance as
BCTs, as per the inclusion criteria.
Outcome. Three studies evaluated walking ability (MWA or
PFWA) by treadmill protocol using a graded progressive
treadmill test,8,23,25 and one used a constant load treadmill
test.24 Two RCTs included data on self-reported walking
ability using the WIQ.8,23 Three studies reported dailywalking activity, two which used step activity monitors8,26
and one which used a standard questionnaire (Interna-
tional Physical Activity Questionnaire) to assess self-
reported walking activity (Table 1).
Risk of bias in individual studies
The mean (range) score using the quality assessment tool
by Downs and Black20 was 20 (12e26). Possible bias
occurred in several studies because of inadequate allocation
concealment23e25,27 and none of the included studies
blinded outcome assessment (Table 3).
Effect of interventions
Maximal walking ability at least 3 months after the start of
an intervention. Four studies reported data on MWA
(Table 4 and Supplementary Table 1).8,23e25 One high-
quality trial reported signiﬁcantly greater improvements in
MWA at 3 months in the intervention versus control groups
(MD D 134.0 seconds [95% CI: 39.7 to 228.3]; p ¼ .005).8
That study compared walking advice plus BCTs with
walking advice alone. Among low-quality trials, one study
reported improvements in 3-month MWA following BCTs
plus walking advice and weekly SET versus walking advice
alone (median D 130% vs. control 70%; p < .001).24 Two
low-quality RCTs demonstrated no beneﬁt of intervention
versus control on MWA. One showed no difference 3
months following BCTs plus walking advice compared with
walking advice alone (MD 3.9 minutes [95% CI: 8.2 to
1.1]; p ¼ .13),25 and one showed no difference at 6 months
following BCTs plus walking advice and weekly SET versus a
non-exercise attention placebo group (MD 14.7 metres
[95% CI: 69.0 to 39.6]; p ¼ .60).23
Pain-free walking ability at least 3 months following the
start of an intervention. Three studies reported data on
PFWA (Table 4 and Supplementary Table 1). One high-
quality trial8 reported greater improvements in PFWA at 3
months following BCTs plus walking advice compared with
walking advice alone (MD D 150.0 seconds [95% CI: 65.5 to
234.5]; p ¼ .0005). Among low-quality trials, there was no
difference in PFWA at 3 months following BCTs plus walking
advice compared with walking advice alone (MD 2.0 mi-
nutes [95% CI: 5.7 to 1.7]; p ¼ 0.29)25 or at 6 months
following BCTs plus walking advice and weekly SET versus an
attention placebo group (MD 14.4 metres [95% CI: 47.5 to
76.3]; p ¼ .65).23
Self-report walking ability at least 3 months following the
start of an intervention. Data on self-report walking ability
was available from two studies (Table 4 and Supplementary
Table 1). One high-quality trial found no difference at 3
months in self-report walking ability following BCTs plus
walking advice (mean  SD D for distance 10.0  25.0 and
speed 11.0  22.0) versus walking advice alone (mean  SD
D for distance 1.0  34.0 and speed 4.0  25.0; both
p ¼ NS).8 One low-quality trial reported mixed ﬁndings.
There was a greater improvement in self-report walking
speed (mean  SE D 5.7  2.2 versus control 1.9  2.8;
Table 1. Characteristics of randomised controlled trials included in the systematic review.
First author Participants
(n ¼ 434)
Exercise intervention BCTs used BCT delivery Control Outcome measure
Cunningham26 n ¼ 58 (67% M),
mean 65.3 y, 36%
current smokers,
mean ABI 0.70,
early IC
Walking advice þ BCT Information on consequences
of walking exercise, behavioural
goal setting, action planning,
barrier identiﬁcation/problem
solving, motivational interviewing
Individual consultation
with a trainee health
psychologist (2  1 h,
1 wk apart) delivered
at home
Walking advice plus
attention placebo
DWA (step activity monitor)
at 4 mo
Gardner8 n ¼ 119 (48% M),
mean 65 y, 10%
current smokers,
mean ABI 0.73,
established IC
Walking advice þ BCT Self-monitoring, performance
feedback
Individual consultation
with an exercise
physiologist (7  15
min, 2/mo)
Walking advicea MWA and PFWA (graded
progressive treadmill testb),
SRWA and DWA (step activity
monitor) at 3 mo
Cheetham24 n ¼ 59 (73% M),
mean 67 y, 100%
current or ex-smokers,
mean ABI 0.69,
established IC
Walking advice and SET
(1  30 min/wk for 6 mo)
þ BCT
Information on consequences
of walking exercise
Motivation class
(1  5e10 min/wk
for 6 mo) delivered in
conjunction with SET
Walking advice MWA (constant-load treadmill
testc) up to 12 mo
Christman25 n ¼ 30 (55% M),
mean 66.9 y, 47%
current smokers,
mean ABI 0.61,
established IC
Walking advice þ BCT Barrier identiﬁcation/problem
solving, self-monitoring,
performance feedback,
behavioural contract, follow-up
prompts, planning social support
Small group counselling
(1  1 h/wk for 12 wk)
Walking advice MWA and PFWA (graded
progressive treadmill testd)
up to 6 mo
Collins23 n ¼ 145 (69% M),
mean 66.5 y, 14%
current smokers,
mean ABI 0.95, DM
and established IC
Walking advice and SET
(1  50 min/wk for 6 mo)
þ BCT
Behavioural goal setting, barrier
identiﬁcation/problem solving,
self-monitoring, performance
feedback, prompt practice of
walking, follow-up prompts,
planning social support
Individual consultation
(1  at baseline),
practice exercise
sessions (2  1 h),
follow-up telephone
consultation (1 
biweekly for 6 mo)
Usual care plus
attention-placebo
MWA (graded progressive
treadmill testb) and SRWA
at 6 mo
Quirk27 n ¼ 23 (74% M),
mean 73.2 y, 32%
current smokers,
mean ABI not
reported,
established IC
Walking advice þ BCTe Motivational interviewing Individual consultation
(up to 4  1 h)
Walking advicee DWA (self-report)f
Note. ABI ¼ ankle-brachial index; BCT ¼ behaviour-change technique; DM ¼ diabetes mellitus; DWA ¼ daily walking activity; h ¼ hour; IC ¼ intermittent claudication; M ¼ male;
min ¼ minute; mo ¼ month; MWA ¼ maximal walking ability; PFWA ¼ pain-free walking ability; SET ¼ supervised exercise therapy; SRWA ¼ self-report walking ability (assessed by
the Walking Impairment Questionnaire); wk ¼ week; y ¼ years.
a This was a three-arm trial and included a group receiving SET for which data are not presented.
b Gardner maximal treadmill test:41 3.2 km/h (2.0 mph) constant speed, baseline 0% grade, increasing 2% every 2 min up to 14% at 16 min; maximum distance 0.8 km (0.5 mi).
c 3.0 km/h at a 12% grade up to 15 min.42
d Baseline 1.6 km/h (1.0 mph) and 5% grade, increasing in 5 min intervals to 4.0 km/h (2.5 mph) and 10% grade.
e Conﬁrmed by personal communication with author.
f International Physical Activity Questionnaire, brief version.
136
Eu
ro
p
ean
Jo
u
rn
al
o
f
V
ascu
lar
an
d
En
d
o
vascu
lar
Su
rgery
V
o
lu
m
e
46
Issu
e
1
Ju
ly/2013
Table 2. Summary of behaviour-change techniques identiﬁed in included studies.
Behaviour-change technique Deﬁnitiona
Prompt self-monitoring of behaviour Individuals is asked to keep a record (e.g., diary)
of speciﬁed behaviour as a method of changing
behaviour (i.e., includes explicit intervention
components, rather than a component of
outcome measures for research purposes)
Provide feedback on performance Individual is provided data about their own
recorded behaviour or receives comments on
their behavioural performance
Barrier identiﬁcation/problem solving Individual is prompted to think about potential
barriers (e.g., behavioural, cognitive, emotional,
environmental, social and/or physical) and
identify ways of overcoming them
Use of follow-up prompts Intervention components are gradually reduced
in intensity, duration and/or frequency over time
(e.g., letters or telephone calls are used instead
of face-to-face consultations)
Provide information on consequences of the
behaviour in general
Information about the relationship between the
behaviour and its possible or likely consequences
in the general case, but not personalised for the
individual (e.g., usually based on epidemiological
data)
Goal setting (behaviour) Individual is encouraged to make a behavioural
resolution (i.e., to decide to change or maintain
change)
Plan social support/social change Individual is prompted to plan how to elicit social
support to achieve their target behaviour or
outcome (e.g., includes support from family,
friends or those providing the intervention)
Action planning Involves detailed planning of what the person will
do, including when or how frequently, in which
situation and/or where to engage in behaviour
Motivational interviewing A clinical method including speciﬁc techniques
that prompt the individual to engage in change
talk in order to minimise resistance and resolve
ambivalence to change
Agree behavioural contract A written agreement on the performance of an
explicitly speciﬁed behaviour, including a record
of the resolution that is witnessed by another
Prompt practice Individual is prompted to rehearse and repeat
the behaviour, parts of the behaviour or
preparatory behaviours numerous times (e.g.,
building habits or routines)
a Deﬁnitions are according to the taxonomy of behaviour-change techniques deﬁned by Michie et al.14
M.N. Galea et al. 137p ¼ .034), but not walking distance (mean  SE D 5.6  3.5
vs. control 1.4  3.3; p ¼ .383) following BCTs plus walking
advice and weekly SET versus an attention placebo.23
Daily walking activity at least 3 months following the start
of an intervention. Data on daily walking activity was
available from three studies, including two high-quality
trials (Table 4 and Supplementary Table 1). In one high-
quality study, change in mean 6-day step count was
greater following BCTs plus walking advice versus an
attention placebo plus walking advice (MD 1,674.2 steps
[95% CI: 156.0 to 3,188.4]; p ¼ .03).26 In a second high-
quality study, there was no difference in mean 7-day ac-
tivity time following BCTs plus walking advice versus walking
advice alone (MD 1 min/day [95% CI: 41.1 to 39.1];p ¼ .96).8 In a low-quality pilot RCT, BCTs did not affect self-
reported daily walking activity.27DISCUSSION
This systematic review is the ﬁrst evaluation of BCTs
alongside exercise therapy for improving walking in in-
dividuals with IC. The existing evidence is limited to a small
number of mostly low-quality trials using 11 BCTs, and there
is insufﬁcient evidence to draw conclusions on the effec-
tiveness of these strategies for improving maximal walking
ability. Given that access to SET and adherence to walking
advice is limited among individuals with IC,9,10 this is an
important ﬁnding as it highlights the need for more rigorous
trials of behaviour-change interventions for this population.
Table 3. Risk of bias in randomised controlled trials.
First author Source of biasa Summary risk
of biasb
Quality
indexcRandom sequence
generation
Allocation
concealment
Participant and
personnel blinding
Blinded outcome
assessment
Incomplete
outcome data
Selective
reporting
Cheetham24 Yes Yes Yes Yes No No High 21
Christman25 Yes Yes Yes Yes No No High 15
Collins23 No Yes Yes Yes No Yes High 23
Cunningham26 No Yes No Yes No No Low 24
Gardner8 No No Yes Yes No No Low 26
Quirk27 No Yes Yes Yes Yes No High 12
The presence or potential presence of a source of bias is indicated as ‘yes’.
a Summary risk of bias was determined using the Cochrane Collaboration tool for assessing risk of bias.19
b Studies were rated as having high risk of bias (i.e., ‘low-quality’ trials) or low to moderate risk of bias (i.e., ‘high-quality’ trials) if there was
evidence for the presence of 3 or <3 sources of bias respectively.
c Quality index scores were determined using the quality appraisal tool developed by Downs and Black;20 scores range from 0 to 31, with
higher scores indicating higher study quality and a lower risk of bias.
138 European Journal of Vascular and Endovascular Surgery Volume 46 Issue 1 July/2013Although data from two high-quality trials demonstrate
that BCTs supplementary to exercise prescription improved
maximal and pain-free walking ability8 and increased daily
walking activity,26 further evidence from four low-quality
trials was conﬂicting. The high-quality trials were more
recent publications, and may reﬂect improvements in study
design and reporting, and a growing recognition of the need
to support behaviour-change among IC patients. However,
ﬁndings of both trials were at risk of bias as a result of lack
of blinding of the outcome assessor, which may be impor-
tant given that treadmill walking performance could be
inﬂuenced by interaction with personnel. In addition, oneTable 4. Data extracted from included studies.
First author
Maximal walking ability Pain-free walking a
Cunningham26 e e
Gardner (vs.
walking advice)8
Greater change in walking
time in intervention group
(124  193 s) vs. control
(10  176 s); p < .05
Greater change in w
time in intervention
(134  197 s) vs. c
(16  125 s); p <
Cheetham24 Greater walking distance in
intervention group (median
304 m) vs. control (175 m);
p < 0.001
e
Christman25 p ¼ NS p ¼ NS.
Collins23 p ¼ NS p ¼ NS
Quirk27 e e
Note. NS ¼ non-signiﬁcant; s ¼ seconds. Data are presented as interv
otherwise.
a SD derived from data published as SE.trial was at risk of selection bias because there was no
indication of allocation concealment.
Although RCTs are considered the gold-standard for sys-
tematically evaluating the existing evidence, poor design
and possible bias can reduce the robustness of data.28,29 In
addition, RCTs often lack ecological validity, limiting the
transferability of their ﬁndings to the clinical setting.
Interestingly, before-and-after studies and audits of BCTs
consistently report improvements in MWA among people
with PAD.30e37
Possible explanations for the conﬂicting ﬁndings include
the use of unstandardised treadmill testing protocols forOutcome
bility Self-report walking ability Daily walking activity
Distance Speed
e e Greater change in steps
taken by intervention
group (1,358 steps) vs.
control (227 steps) at
follow-up; p < .001
alking
group
ontrol
.05
p ¼ NS p ¼ NS p ¼ NS
e e e
e e e
p ¼ NS Greater change
in score for
intervention
group (D 5.7
 18.7) vs.
control (1.9
 23.9); p ¼
0.034a
e
e e p ¼ NS
ention versus control and represent mean  SD unless indicated
M.N. Galea et al. 139measuring outcome,25 and heterogeneous patient samples,
for example patients in one trial concomitantly had diabetes
mellitus,23 which could inﬂuence exercise response.38,39
Moreover, although four23,25e27 of the included studies
were designed with the primary objective of examining the
effect of BCTs on walking, two studies8,24 did not deliber-
ately evaluate BCTs, thus compromising their quality
appraisal in this review.
Patient perceived walking performance is an important
clinical outcome, as pain-related symptoms are largely
subjective and because no minimal clinically important
differences for changes in PFWA or MWA have been
established. In the current review, one high-quality study8
reported no change in self-report walking ability, despite
improvements in PFWA and MWA, suggesting that BCTs
might improve walking performance, but not patient per-
ceptions of their walking ability, which may be more
meaningful to them. Future studies evaluating BCTs should
incorporate outcome measures reﬂecting the patient
perception of walking capacity, together with more objec-
tive measures.
This review identiﬁes a total of 11 BCTs, which were
applied to increase walking in individuals with IC. Successful
BCTs included self-monitoring, for example encouraging the
patient to keep a diary of walking behaviour, providing
feedback on walking performance, and helping the patient
to identify barriers to walking and solutions to overcoming
them. These techniques are useful for increasing an in-
dividual’s conﬁdence in their ability to perform walking
exercise and can be easily incorporated into clinical practice
by healthcare professionals when discussing exercise,
particularly home-based walking advice among people with
IC. However, there are at least 29 additional theory-based
techniques classiﬁed by Michie et al.,14 and possibly more
unclassiﬁed techniques, that have not been applied to in-
crease walking among individuals with IC, which warrant
investigation.
Limitations to the included studies meant statistical
synthesis of the data could not be performed because of a
high degree of clinical and methodological heterogeneity,
primarily as a result of variations in intervention protocol
and setting between studies, and lack of control for these
factors within studies. In addition, in two studies,23,24 where
BCTs were provided alongside SET, it was difﬁcult to
distinguish the effects of BCTs above and beyond the ben-
eﬁts of the exercise alone. However, both studies provided
only one supervised exercise session per week, which is a
suboptimal exercise dose that does not meet guidelines for
SET for patients with IC.4,40 Thus, it is possible that the
change in walking ability is not solely attributable to SET in
these studies, and that BCTs targeting self-directed walking
activity might inﬂuence outcomes. Data from the study by
Gardner et al.,8 which applied BCTs to increase self-directed
walking, demonstrate that BCTs have the potential to in-
crease participation such that individuals achieve gains in
walking ability that are at least comparable with SET.
BCTs are intended to target and modify known motiva-
tional factors, for example, a person’s beliefs about walkingand the outcome of performing it, or their ability to carry
out walking as exercise. In order to evaluate the effective-
ness of BCTs, it is necessary to determine whether the
targeted psychosocial constructs change over the course of
an intervention. Because the studies included in this review
did not evaluate the psychosocial constructs underpinning
the BCTs implemented, it was not possible to determine
whether the intervention successfully altered the psycho-
social variables or if other factors inﬂuenced walking.
Moreover, as most interventions combined multiple BCTs,
the independent effects of each could not be determined.
In summary, there is limited evidence from one high-
quality RCT supporting BCTs for increasing MWA and
PFWA, and from one high-quality RCT suggesting that BCTs
might be beneﬁcial for increasing daily walking activity
among people with IC. Eleven BCTs were identiﬁed and
several, in particular self-monitoring, feedback on perfor-
mance and barrier identiﬁcation with problem solving,
could be easily combined with exercise prescription and
walking advice in clinical practice. Future high-quality trials
should explore these and other BCTs, and should evaluate
changes in psychosocial variables that are targeted by
speciﬁc techniques.
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